Editas Medicine, Inc. — Director's Dealing 2020

Jun 12, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Editas Medicine, Inc. (EDIT)
CIK: 0001650664
Period of Report: 2020-06-10

Reporting Person: Hirsch Andrew (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-10	Stock Option (right to buy)	$27.49	A	11538	Acquired	2030-06-09	Common Stock (11538)	Direct

Footnotes

F1: This option was granted on June 10, 2020 and is scheduled to vest in full on June 10, 2021.